Profound Medical
PROF
63 hedge funds and large institutions have $126M invested in Profound Medical in 2025 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 6 closing their positions.
333% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 6
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
133% more capital invested
Capital invested by funds: $54.3M → $126M (+$72M)
47% more funds holding
Funds holding: 43 → 63 (+20)
8.67% more ownership
Funds ownership: 36.73% → 45.4% (+8.7%)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$4.36M |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$2.42M |
| 3 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
+$2.42M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$2.02M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.29M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
-$104K |
| 3 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
-$100K |
| 4 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
-$81.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$81.6K |
PROF Hedge Fund Activity: Q4 2025 in Review
63 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2025, worth a combined $126M — up 133% from $54.3M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new PROF positions and 6 closed out — a net gain of 20 holders — while 18 added to existing stakes and 7 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $4.36M. The largest seller was Bank of America, cutting an estimated $1.29M.
- 63 institutional investors held Profound Medical (PROF) as of Q4 2025, up from 43 in Q3 2025.
- Funds reported $126M of Profound Medical stock for Q4 2025, up 133% quarter-over-quarter.
- 26 funds opened new Profound Medical positions in Q4 2025 and 6 closed out, a net change of +20 holders.
- The largest Profound Medical buyer in Q4 2025 was Alyeska Investment Group, an estimated $4.36M added.
- The largest Profound Medical seller in Q4 2025 was Bank of America, an estimated $1.29M sold.
Based on aggregated 13F filings for Q4 2025.